uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease
Show others and affiliations
2015 (English)In: Cancer Cell, ISSN 1535-6108, E-ISSN 1878-3686, Vol. 27, no 1, 72-84 p.Article in journal (Refereed) Published
Abstract [en]

We undertook a comprehensive clinical and biological investigation of serial medulloblastoma biopsies obtained at diagnosis and relapse. Combined MYC family amplifications and P53 pathway defects commonly emerged at relapse, and all patients in this group died of rapidly progressive disease postrelapse. To study this interaction, we investigated a transgenic model of MYCN-driven medulloblastoma and found spontaneous development of Trp53 inactivating mutations. Abrogation of p53 function in this model produced aggressive tumors that mimicked characteristics of relapsed human tumors with combined P53-MYC dysfunction. Restoration of p53 activity and genetic and therapeutic suppression of MYCN all reduced tumor growth and prolonged survival. Our findings identify P53-MYC interactions at medulloblastoma relapse as biomarkers of clinically aggressive disease that may be targeted therapeutically.

Place, publisher, year, edition, pages
2015. Vol. 27, no 1, 72-84 p.
National Category
Cancer and Oncology Neurology
Identifiers
URN: urn:nbn:se:uu:diva-244483DOI: 10.1016/j.ccell.2014.11.002ISI: 000347906900011OAI: oai:DiVA.org:uu-244483DiVA: diva2:790743
Available from: 2015-02-25 Created: 2015-02-17 Last updated: 2017-12-04Bibliographically approved

Open Access in DiVA

fulltext(6568 kB)211 downloads
File information
File name FULLTEXT01.pdfFile size 6568 kBChecksum SHA-512
16d5a92872eac9a60bd0ad3eb0ef9ea7d7b35a002b412436705221591e1cc7e9398b4cf6bc0d86bd1dbb8f229dd2e4c5ad7c6f26fb64b1961105db98dd10d072
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Authority records BETA

Swartling, Fredrik J.

Search in DiVA

By author/editor
Swartling, Fredrik J.
By organisation
Neuro-Oncology
In the same journal
Cancer Cell
Cancer and OncologyNeurology

Search outside of DiVA

GoogleGoogle Scholar
Total: 211 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 724 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf